Friday, April 16, 2021

Early Results from First-In-U.S. Trial of CRISPR-Edited Immune Cells for Cancer Patients Suggest Safety of Approach - Penn Medicine

This is not Breaking news but it is just coming to my attention now and is very exciting news.

No comments:

Post a Comment

Please be constructive in your comments.